[go: up one dir, main page]

MX2020012810A - Formulación de nicotina. - Google Patents

Formulación de nicotina.

Info

Publication number
MX2020012810A
MX2020012810A MX2020012810A MX2020012810A MX2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A MX 2020012810 A MX2020012810 A MX 2020012810A
Authority
MX
Mexico
Prior art keywords
nicotine formulation
nicotine
formulation
relates
via inhalation
Prior art date
Application number
MX2020012810A
Other languages
English (en)
Other versions
MX390509B (es
Inventor
Christopher Nolan
Joseph Kavanagh
Kieran Raleigh
Brian O''rourke
Original Assignee
Yatzz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yatzz Ltd filed Critical Yatzz Ltd
Publication of MX2020012810A publication Critical patent/MX2020012810A/es
Publication of MX390509B publication Critical patent/MX390509B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)

Abstract

La invención se refiere a una formulación farmacéutica que comprende nicotina; la formulación puede ser dispersa en un gas a temperatura ambiente para su suministro por medio de inhalación; la invención se refiere también a un método de suministro de nicotina a un sujeto por medio de inhalación, y específicamente por medio del uso de un nebulizador.
MX2020012810A 2018-06-01 2019-05-31 Formulación de nicotina. MX390509B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18175640.4A EP3574902A1 (en) 2018-06-01 2018-06-01 Nicotine formulation and mode of delivery
PCT/EP2019/064212 WO2019229249A1 (en) 2018-06-01 2019-05-31 Nicotine formulation

Publications (2)

Publication Number Publication Date
MX2020012810A true MX2020012810A (es) 2022-03-08
MX390509B MX390509B (es) 2025-03-11

Family

ID=62528283

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012810A MX390509B (es) 2018-06-01 2019-05-31 Formulación de nicotina.

Country Status (12)

Country Link
US (2) US11833145B2 (es)
EP (3) EP3574902A1 (es)
JP (1) JP7224375B2 (es)
CN (1) CN112218637A (es)
AU (2) AU2019276357B2 (es)
BR (1) BR112020024088B1 (es)
ES (1) ES2883799T3 (es)
MA (2) MA50205B1 (es)
MX (1) MX390509B (es)
PL (1) PL3684362T3 (es)
SG (1) SG11202011761XA (es)
WO (1) WO2019229249A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817868D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
MX2021007624A (es) * 2018-12-31 2021-08-11 Philip Morris Products Sa Formulacion de nicotina liquida.
WO2020254862A1 (en) 2019-06-20 2020-12-24 Shaheen Innovations Holding Limited Personal ultrasonic atomizer device
FR3102041B1 (fr) * 2019-10-22 2025-02-14 Aroma Sens Edulcorant pour liquides de cigarette électronique
US12262738B2 (en) 2019-12-15 2025-04-01 Shaheen Innovations Holding Limited Ultrasonic mist inhaler
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
WO2021123753A1 (en) 2019-12-15 2021-06-24 Shaheen Innovations Holding Limited Mist inhaler devices
ES3041582T3 (en) 2019-12-15 2025-11-13 Shaheen Innovations Holding Ltd Ultrasonic mist inhaler
ES3028096T3 (en) 2019-12-15 2025-06-18 Shaheen Innovations Holding Ltd Ultrasonic mist inhaler
US12121056B2 (en) 2019-12-15 2024-10-22 Shaheen Innovations Holding Limited Hookah device
US11944120B2 (en) 2019-12-15 2024-04-02 Shaheen Innovations Holding Limited Ultrasonic mist inhaler with capillary retainer
JP7578712B2 (ja) 2019-12-15 2024-11-06 シャヒーン イノベーションズ ホールディング リミテッド 超音波ミスト吸入器
US12233207B2 (en) 2019-12-15 2025-02-25 Shaheen Innovations Holding Limited Mist inhaler devices
US12201144B2 (en) 2019-12-15 2025-01-21 Shaheen Innovations Holding Limited Hookah device
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
CN114828663B (zh) * 2019-12-18 2024-07-09 菲利普莫里斯生产公司 用于气溶胶生成系统的制剂
JP7609561B2 (ja) * 2020-02-05 2025-01-07 日本たばこ産業株式会社 液体加熱式の加熱型香味吸引器用の液体組成物
MX2022012002A (es) 2020-03-27 2023-01-05 Mcneil Ab Cartucho con nicotina.
MA57567B1 (fr) * 2020-04-06 2022-09-30 Shaheen Innovations Holding Ltd Dispositifs d'inhalateur de brouillard
CN111802686A (zh) * 2020-07-27 2020-10-23 湖北中烟工业有限责任公司 含脂肪酸、植物油的雾化剂以及加热不燃烧卷烟
CN111855866A (zh) * 2020-08-25 2020-10-30 甘肃烟草工业有限责任公司 一种快速测定烟用添加剂中甲醛的方法
EP4041002B1 (en) * 2020-12-15 2024-02-28 Shaheen Innovations Holding Limited A nicotine delivery device
CN114947174A (zh) * 2021-02-25 2022-08-30 深圳市合元科技有限公司 气溶胶形成基质以及气溶胶生成系统
CN113197330A (zh) * 2021-04-28 2021-08-03 深圳市博睿生物科技有限公司 一种电子烟新型甜味剂及制备方法及应用
IL283002A (en) * 2021-05-06 2022-12-01 Nicogen Ltd Nicotine formulations and aerosols
CN113912585B (zh) * 2021-11-09 2023-02-24 深圳萨特瓦生物科技有限公司 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves
CN116326810A (zh) * 2021-12-22 2023-06-27 深圳市富淼生物科技有限公司 水基雾化剂、指定用途水基雾化物、雾化弹以及雾化装置
KR20240012197A (ko) * 2022-07-20 2024-01-29 주식회사 케이티앤지 표면파 아토마이저에 사용하기 위한 액상형 흡입제형, 이를 포함하는 카트리지 및 에어로졸 생성장치
KR102872477B1 (ko) * 2022-08-10 2025-10-20 주식회사 케이티앤지 니코틴 흡입성 조성물 및 이를 포함하는 에어로졸 발생 장치 및 시스템
CN116019250B (zh) * 2022-12-22 2025-02-14 东莞市吉纯生物技术有限公司 基于酸性电解水的雾化液、制备方法和酸性电解水制备方法
WO2024138377A1 (zh) * 2022-12-27 2024-07-04 思摩尔国际控股有限公司 一种雾化液、雾化器及电子雾化装置
EP4658106A1 (en) * 2023-01-31 2025-12-10 RAI Strategic Holdings, Inc. Stabilized aerosol precursor formulations
CN118787123A (zh) * 2023-04-14 2024-10-18 思摩尔国际控股有限公司 一种水基电子烟雾化制剂及其制备方法和应用
PL446676A1 (pl) * 2023-11-08 2025-05-12 Dmitrii Shesternenko Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję
FR3159394A1 (fr) * 2024-02-19 2025-08-22 Swm Holdco Luxembourg Feuille de papier comprenant un extrait de plante et de la nicotine stabilisée
CN117898466B (zh) * 2024-02-29 2024-09-24 深圳市艾斯摩迪斯科技有限公司 一种复合尼古丁盐的制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
KR102490695B1 (ko) * 2013-05-06 2023-01-19 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
EP3021699B1 (en) * 2013-07-19 2023-09-13 Altria Client Services LLC Liquid aerosol formulation of an electronic smoking article
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery

Also Published As

Publication number Publication date
MA54714A (fr) 2021-11-17
WO2019229249A1 (en) 2019-12-05
CN112218637A (zh) 2021-01-12
AU2023202855B2 (en) 2024-08-22
US20210196700A1 (en) 2021-07-01
MX390509B (es) 2025-03-11
AU2019276357A1 (en) 2020-11-26
ES2883799T3 (es) 2021-12-09
BR112020024088A2 (pt) 2021-02-17
JP7224375B2 (ja) 2023-02-17
US20240050424A1 (en) 2024-02-15
EP3684362A1 (en) 2020-07-29
MA50205A (fr) 2020-07-29
AU2019276357B2 (en) 2023-04-20
NZ769793A (en) 2024-05-31
EP3684362B1 (en) 2021-06-23
EP3574902A1 (en) 2019-12-04
PL3684362T3 (pl) 2021-12-20
MA50205B1 (fr) 2021-09-30
AU2023202855A1 (en) 2023-05-25
US11833145B2 (en) 2023-12-05
SG11202011761XA (en) 2020-12-30
JP2021526147A (ja) 2021-09-30
EP3909581A1 (en) 2021-11-17
BR112020024088B1 (pt) 2022-10-11
CA3099940A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
MX2020012810A (es) Formulación de nicotina.
ZA202000494B (en) Nicotine salts and methods of making and using same
EP4552512A3 (en) Nicotine liquid formulations for aerosol devices and methods thereof
PH12018502738A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
EP4430962A3 (en) Nicotine salt formulations for electronic cigarettes and method of delivering nicotine
MX2016015179A (es) Una formulación líquida que comprende nicotina para administracion en aerosol.
PH12018502109A1 (en) Medicine obtained by combining fxr agonist and arb
MY176176A (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
PH12015502593A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS
PH12017501486A1 (en) Nasal powder formulation for treatment of hypoglycemia
MX335944B (es) Composiciones que comprenden sulfato de salbutamol.
MY184362A (en) Inhalable nicotine formulations, and methods of making and using thereof
MX2016005232A (es) Formulaciones liposomicas para inhalacion, modificadas con agente tensoactivo, que proveen un perfil de liberacion tanto inmediata como sostenida.
MX370890B (es) Composición que comprende sulfato de salbutamol.
MX2023003230A (es) Procesos e intermediario para la preparacion a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbon il)-piridin-2-il]-benzamida y preparacion de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il ]-benzamida.
CL2017001859A1 (es) Inhalador de polvo seco que comprende propionato de fluticasona y xinafosfato de salmeterol
EP3661576A4 (en) MEDICAL NEBULIZER FOR FAST DRUG DELIVERY
MX2019010263A (es) Formulaciones de nicotina inhalables y metodos de fabricacion y uso de las mismas.
MX2017013950A (es) Polvos de zolmitriptán para suministro pulmonar.
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
NZ744942A (en) Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
ZA202003904B (en) Drug delivery system
PH12021551465A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
WO2015130963A3 (en) Compositions and methods for administering insulin or insulin-like protein to the brain
MY206419A (en) Hepatitis b vaccine transnasal administration system